Our business development managers and directors are extraordinarily skilled at working closely with clients to take advantage of the Medical Intelligence Solutions database to answer key, business critical questions, including:
What does the current and future competitive landscape look like for a therapeutic area or class of drugs?
What drug targets are currently being analyzed for a particular disease indication?
Which of your competitors are actively developing new therapies in those therapeutic areas and what are their chances of success? What is the quantity and quality of your competitors' studies?
Where are the growth opportunities and threats?
What are the most promising candidates for business development and what is their progress over time?
What do thought leaders and practicing physicians think about specific therapies as well as the current and future landscape
Whether you need to perform due diligence, take stock of a new market and its trends, profile licensing candidate or competitors, this service will help you answer key questions, validate assumptions, and clarify your threats and opportunities.
Business Development clients report thatMedical Intelligence Solutions Custom Analytics is a source of significant time savings, pinpointing its ability to answer questions based on a complete review of the clinical landscape, including all potential opportunities and threats.
Custom Analytics key facts:
Projects begin with intensive and thorough discussions between you and our analysts to ensure that we provide the precise answers relevant to your research and development needs
The analysis benchmarks worldwide medical meeting content against published literature abstracts to provide a complete look at the clinical landscape
We deliver an easy to use, one point access, interactive platform centered on analyst insights and clinical findings that are pertinent to YOUR particular area of interest
Real-time tracking of speaking/publishing activities is available for key drug candidates or selected thought leaders.
Projects can incorporate primary research on physician reactions to drugs, indications, and treatment strategies
)